Christine Lynn Lanning

Christine Lynn Lanning

Distinguished Scientist

Merck Sharp & Dohme (MSD)

United States


Dr. Christine Lynn Lanning is a Distinguished Scientist at MSD where she oversees the biocompatibility of the medical device/medical device combination product portfolio. She has a PhD from Duke University in Pharmacology/Toxicology and has been at MSD over 20 years with expertise in nonclinical drug and device development. Her previous roles include: Toxicologist/Study Director overseeing the conduct of toxicity studies from single dose to 2 years in duration; Compound Leader responsible for the compound’s nonclinical toxicology development program; Regulatory Affairs Liaison interacting with Health Authorities regarding development programs; and the Head of Toxicological Sciences where she managed the entire portfolio of toxicology studies. She has authored over 200 scientific reports and over 50 regulatory submissions.

Speaker Details